Related Experiment Video
Updated: May 10, 2025
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Variations in Complete Blood Counts in Patients With Non-hematological Malignancies: Insights From a Retrospective
Garima Anandani1, Vaishali Bhankhodia1, Sagar Dholariya2
1Pathology, All India Institute of Medical Sciences, Rajkot, Rajkot, IND.
Introduction:
Malignancy ranks among the leading causes of mortality in both developed and developing nations. An abnormal hematological profile may serve as the initial indication of various non-hematological malignancies or solid tumors. Aims and objectives: This research aims to investigate the spectrum of hematological alterations in individuals diagnosed with non-hematological cancers, evaluate their prevalence, and determine the relationship between complete blood count results and specific types of malignancies at a tertiary care facility in Gujarat.
Materials And Methods:
We compiled the retrospective data of 135 cases diagnosed with non-hematological malignancies through histopathological examination, all of whom had a CBC report and sought consultation at our hospital between January 2022 and December 2024. The CBC reports for all included cases were thoroughly analyzed. Statistical analysis was performed using the Statistical Package for Social Sciences version 28.0 (IBM Corp., Armonk, NY). Continuous variables were expressed as mean ± standard deviation, while categorical variables were represented as counts and percentages.
Results:
There was a male preponderance amongst cases with head and neck (HN) cancer as the most common non-hematological malignancy. Anemia was observed as an important hematological finding predominantly in female patients. Leucocytosis, neutrophilia, eosinophilia, and thrombocytosis were also identified in some cases, especially in those who were non-anemic. HN cancer and malignancies of the female genital tract demonstrated significant anemia, lung tumors had markedly elevated red blood cell counts, and breast cancer patients were associated with thrombocytosis.
Conclusion:
The current research demonstrated a definite correlation between hematological manifestations, such as anemia, leucocytosis, and thrombocytosis, and various non-hematological malignancies. Early detection of these conditions during disease progression can significantly reduce associated morbidity and mortality, ultimately contributing to improved patient care.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
05:58Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Related Concept Videos
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:15Differentiation of Common Myeloid Progenitor Cells
01:01Regulation of Hematopoietic Stem Cells
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.